Home » Newsletters » BioWorld Science

BioWorld Science

March 23, 2018

View Archived Issues

Merck & Co. identifies novel IDO-1 inhibitors

Processa Pharmaceuticals assigned license for CTP-499

DiscGenics studies IDCT in patients with symptomatic lumbar intervertebral disc degeneration

New phase II trial explores SAR-440340 alone and with dupilumab for moderate to severe asthma

SemaThera signs financing and licensing deal for ST-102

Zhejiang Hisun Pharmaceutical identifies new anti-HBV compounds

Discovery of novel potent BRAF inhibitor for the treatment of cancer

EMA reports negative CHMP assessment for abaloparatide-SC

Roche describes new TLR7 agonists and HBsAg secretion inhibitors

Novel PD-1/PD-L1 interaction inhibitors derived at Polaris Pharmaceuticals

Ohio State University, Georgia State University patent antiparasitic compounds

CARB-X and Shionogi partner to develop a novel antibiotic

OP-1074, a new candidate for ER-positive breast cancer

Soligenix receives E.U. orphan designation for RiVax

Argenx expands pipeline with ARGX-117 for autoimmune diseases

Lokelma receives E.U. approval for hyperkalemia

TSP5 linked to bladder cancer progression and survival

Galafold approved in Japan for Fabry disease

AZD-0364 demonstrates efficacy in preclinical models of NSCLC

EMA committee hands down positive opinion for Cabometyx

Ozempic approved in Japan

Japanese orphan drug designation awarded to gilteritinib for FLT3 mutation-positive AML

Dracen Pharmaceuticals receives investment for immuno-metabolism agents

Shingrix obtains approvals in E.U. and Japan

Annual Drugs to Watch report names 12 new potential blockbuster drugs

FDA expands Tasigna indications for pediatric patients with CML

vTv Therapeutics completes phase Ib of Simplici-T1 trial of TTP-399 in type 1 diabetes

CBT Pharmaceuticals licenses anti-CTLA-4 monoclonal antibody from Crown Bioscience

First preclinical data presented for VNRX-5133

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...